How Much Is the Lowest Dose of Wegovy in the UK?

What NICE and the licensed schedule actually say about 0.25mg

Wegovy's titration schedule is set out in its Summary of Product Characteristics and reflected in NICE's appraisal of semaglutide for weight management (TA875): treatment begins at 0.25mg weekly, stepping up through 0.5mg, 1.0mg and 1.7mg to the standard 2.4mg maintenance dose, with roughly four weeks at each level. The 0.25mg dose is purely an introductory step. Its job is to let your body settle before the therapeutic doses begin, the weight-loss evidence comes from the 2.4mg maintenance phase and above.

That matters for cost because most private providers price by pen or by calendar month. The 0.25mg pens and the 2.4mg pens are the same Wegovy product; what changes is how many weekly doses each pen contains and what clinical support accompanies the supply. Eli Lilly raised Mounjaro's UK list price substantially from September 2025, and semaglutide prices across the private market have moved in a similar direction over the same period, and if you want to understand how much a dose of Wegovy costs at each stage of the schedule, that varies more than most headline figures suggest. Those figures are widely reported but shift with supply, so any specific monthly cost is best confirmed at consultation rather than taken from a headline.

Worth noting: the MHRA approved a single-dose 7.2mg Wegovy pen in April 2026, extending the maintenance ceiling. The starting dose hasn't changed; only the upper end of the schedule has.

Why the starter-dose price rarely tells you what treatment will cost

A question our prescribers hear regularly: "Can I just stay on the lowest dose to keep costs down?" The honest answer is that 0.25mg is not a dose your prescriber would maintain indefinitely, the clinical plan is titration. So the cost of treatment over time reflects the doses you'll actually reach, not the week-one figure. Wegovy pricing across each dose level gives a clearer picture of what the full schedule looks like privately.

Headline prices also frequently omit the things that surround a legitimate prescription: a clinical consultation fee, the written prescription itself, tracked delivery, and any follow-up if you have questions or side effects. Add those separately and the "low" starter price grows. At nume, one transparent fee covers the consultation, prescription, treatment, free next-working-day DPD delivery and ongoing aftercare, no itemised additions. We're not the cheapest option on a comparison table; that's deliberate. What you're paying for is a single, all-in figure with nothing hidden, reviewed by a real clinician every time.

If you want to see how a complete month of treatment is structured and what's included, the full Wegovy cost guide walks through it clearly, and for those researching the lowest price for Wegovy available through legitimate UK providers, that guide also explains what separates a genuinely competitive price from one that cuts corners.

The supply chain question that cheapest prices can't answer

The MHRA has warned publicly about counterfeit weight-loss pens sold online, and enforcement in 2025 led to seizures of around 20 million doses of illegally traded weight-loss medicines (roughly £45m in street value). Fake pens have been found to contain insulin rather than semaglutide, with serious consequences for patients who had no idea. The risk isn't theoretical.

For a prescription medicine, price is the wrong test. The right questions are: is this pharmacy registered on the GPhC register (verifiable at GPhC registration 9012878)? Has a named prescriber, not software, assessed whether this medicine is appropriate for you? Does the supply come through the licensed UK chain? A small saving against a provider who can't answer those questions isn't a saving. You can report suspect sellers directly through the MHRA's Yellow Card scheme.

If you've been looking at what others have spent on Wegovy, the clinical trial results put the cost in context alongside what the evidence shows for weight loss at maintenance doses, useful reading before deciding what matters most to you.

How to check whether Wegovy is clinically appropriate for you

Wegovy is licensed for adults with a BMI of 30 or above, or 27 and above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes or high cholesterol. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance. A BMI figure alone doesn't determine suitability, a prescriber looks at the whole picture, including your medical history and any medicines you already take.

At nume, a GPhC-registered Independent Prescriber reviews every consultation personally on the day it's submitted. Orders placed before 12pm Monday to Friday are dispatched the same day once clinically approved, arriving the next working day via DPD. Your pen goes in the fridge door when it arrives; the clinical conversation that got it there was never automated. To see current treatment pricing and start your free consultation, the eligibility check takes a few minutes, and if you're weighing up whether to begin the programme it's also worth reading about how much one dose of Wegovy costs so you have a realistic sense of the outlay from week one. You can also read more about how the service works on our about page.